Lineage, Inc. (LINE) AI Stock Analysis

• Market Cap: $7.79B
• Dividend Yield: 6.18%
• Average Volume (3M): 1.65M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.35
• Revenue Growth: 0.44%
• EPS Growth: 75.40%
• Country: US
• Employees: 26,000
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Industrial
• EPS (TTM): -0.44
• Shares Outstanding: 228,289,630
• 10 Day Avg. Volume: 2,088,211
• 30 Day Avg. Volume: 1,647,776
• PEG Ratio: -0.02
• Price to Book (P/B): 1.30
• Price to Sales (P/S): 2.09
• P/FCF Ratio: 932.24
• Enterprise Value/Market Cap: 1.36
• Enterprise Value/Revenue: 1.97
• Enterprise Value/Gross Profit: 6.14
• Enterprise Value/Ebitda: 10.59
• 1Y Price Target: $39.40
• Price Target Upside: 13.48% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 15
• EPS Forecast (FY): -0.1
• Revenue Forecast (FY): $5.41B

• Rating: 54 Neutral
• Price Target: $36.00 ▲(3.69% Upside)

Lineage, Inc. faces significant challenges with profitability and technical indicators pointing to a bearish trend. While the company has a strong dividend yield and recent leadership changes are positive, these factors are overshadowed by operational inefficiencies and lowered guidance. The stock score reflects these mixed signals, with financial performance and technical analysis being the most significant factors.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong demand for Lineage's products and services, supporting long-term business expansion and market presence.

Leadership Changes

New leadership with extensive experience is expected to enhance strategic direction and improve financial management, driving future growth.

Global Integrated Solutions Growth

Strong growth in this segment highlights successful business strategies and positions Lineage well in expanding markets, supporting long-term profitability.

Negative Factors

Profitability Challenges

Negative profitability indicates operational inefficiencies and cost management issues, which could hinder financial stability and growth potential.

Interest Expense Increase

Rising interest expenses could pressure cash flows and limit investment in growth initiatives, impacting long-term financial health.

Lowered Guidance

Lowered financial guidance reflects challenges in market conditions and operational performance, potentially affecting investor confidence and future growth.

Lineage, Inc. Business Overview & Revenue Model

Company Description

Lineage, Inc. (LINE) is a biotechnology company focused on developing innovative solutions in the field of regenerative medicine and cellular therapies. The company operates primarily in the healthcare sector, leveraging its proprietary technologies to produce and commercialize advanced therapies aimed at treating various diseases and conditions. Lineage's core products include stem cell-derived therapies and tissue engineering solutions, with a strong emphasis on applications for spinal cord injuries, retinal diseases, and other chronic conditions.

How the Company Makes Money

Lineage, Inc. generates revenue through multiple streams, including the commercialization of its stem cell therapies and partnerships with pharmaceutical and biotechnology companies for research and development collaborations. The company often enters into licensing agreements that allow it to earn royalties on sales of products developed using its proprietary technologies. Additionally, Lineage may receive milestone payments tied to the success of clinical trials and regulatory approvals of its therapies. Strategic partnerships with academic institutions and research organizations also play a crucial role in funding its development programs, further contributing to its revenue generation.

Lineage, Inc. Financial Statement Overview

Summary

Lineage, Inc. demonstrates stable revenue and operational cash flow, but faces challenges with profitability and free cash flow generation. The balance sheet is moderately leveraged, with a reasonable equity position. The company needs to address its operational inefficiencies and improve profitability to enhance its financial health.

Income Statement

Lineage, Inc. has shown stable revenue over the past year, with a slight decline from the previous year. The gross profit margin is healthy at approximately 33%, but the net profit margin is negative due to significant net losses. The EBIT and EBITDA margins indicate operational challenges, with EBIT being particularly low, suggesting high operating expenses or other costs impacting profitability.

Balance Sheet

The company's balance sheet reflects a moderate debt-to-equity ratio, indicating a balanced approach to financing. However, the return on equity is negative due to net losses, which is a concern for investors. The equity ratio is around 46%, showing a reasonable level of equity financing relative to total assets.

Cash Flow

Lineage, Inc. has a positive operating cash flow, which is a good sign of operational efficiency. However, free cash flow is minimal, indicating limited cash available after capital expenditures. The operating cash flow to net income ratio is strong, but the free cash flow to net income ratio is low, reflecting challenges in generating free cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2018
Income Statement
Total Revenue	5.36B	5.34B	5.34B	4.93B	3.70B	517.82M
Gross Profit	1.72B	1.76B	1.75B	1.46B	1.13B	517.82M
EBITDA	999.00M	547.00M	1.24B	976.00M	632.90M	386.30M
Net Income	-177.00M	-664.00M	-77.00M	-63.00M	-153.30M	-140.67M
Balance Sheet
Total Assets	19.20B	18.66B	18.87B	18.56B	16.42B	2.75B
Cash, Cash Equivalents and Short-Term Investments	75.00M	173.00M	68.00M	170.60M	209.10M	89.06M
Total Debt	7.90B	6.88B	11.05B	10.69B	9.60B	1.03B
Total Liabilities	9.81B	8.97B	12.85B	12.45B	11.14B	1.25B
Stockholders Equity	8.38B	8.64B	5.05B	5.17B	4.34B	1.50B
Cash Flow
Free Cash Flow	135.00M	12.00M	30.00M	-312.00M	-359.20M	265.06M
Operating Cash Flow	654.00M	703.00M	796.00M	501.00M	329.90M	268.30M
Investing Cash Flow	-1.10B	-919.00M	-1.07B	-2.37B	-3.41B	-689.09M
Financing Cash Flow	118.00M	320.00M	136.00M	1.84B	3.03B	426.21M

Lineage, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 34.72
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LINE, the sentiment is Negative. The current price of 34.72 is below the 20-day moving average (MA) of 35.54, below the 50-day MA of 36.67, and below the 200-day MA of 43.07, indicating a bearish trend. The MACD of -0.41 indicates Positive momentum. The RSI at 44.62 is Neutral, neither overbought nor oversold. The STOCH value of 20.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LINE.

Lineage, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EGP	78 Outperform	$9.64B	37.90	7.83%	3.15%	11.10%	-1.65%
REXR	76 Outperform	$9.58B	29.02	4.03%	4.23%	10.27%	15.25%
STAG	75 Outperform	$6.96B	28.78	7.17%	4.01%	9.62%	31.08%
TRNO	75 Outperform	$6.27B	19.34	8.38%	3.35%	21.13%	74.37%
FR	74 Outperform	$7.93B	32.50	8.97%	2.95%	9.66%	-23.17%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
LINE	54 Neutral	$7.79B	-44.25	-2.06%	6.18%	0.44%	75.40%

Lineage, Inc. Corporate Events

Lineage, Inc. Issues €700 Million Senior Notes

On November 26, 2025, Lineage Europe Finco B.V., an indirect subsidiary of Lineage, Inc., issued €700 million in 4.125% Senior Notes due 2031. These notes are senior unsecured obligations, guaranteed by Lineage, Inc. and its subsidiaries, excluding certain entities. The proceeds, approximately €689 million after expenses, will be used to repay amounts under the company’s revolving credit facility and for general corporate purposes. The issuance aims to strengthen Lineage’s financial position, offering flexibility in managing its debt obligations. The notes are subject to various covenants and redemption options, with interest payments commencing in 2026. The notes are not registered under the Securities Act and are sold to qualified institutional buyers and non-U.S. persons under specific regulations.

Lineage, Inc. Prices €700M Senior Notes Offering

On November 19, 2025, Lineage, Inc. announced that its subsidiary, Lineage Europe Finco B.V., priced an offering of €700 million in senior unsecured notes due 2031. The notes, with an interest rate of 4.125% per annum, will be fully guaranteed by Lineage and its subsidiaries, excluding certain entities, and are intended for qualified institutional buyers outside the U.S. The proceeds will be used to repay the company’s revolving credit facility and for general corporate purposes.

Lineage, Inc. Announces Euro Senior Notes Offering

On November 19, 2025, Lineage Europe Finco B.V., a subsidiary of Lineage, Inc., announced the initiation of a private offering of euro-denominated senior notes. These notes, which are senior unsecured obligations, will be guaranteed by Lineage, Inc. and its subsidiaries, excluding certain entities. The proceeds from this offering are intended to repay amounts under the company’s revolving credit facility and for general corporate purposes. The offering is targeted at qualified institutional buyers and non-U.S. persons, with specific restrictions for retail investors in the EEA and UK. The announcement highlights potential risks and uncertainties related to market conditions and regulatory changes that could impact the offering’s success.

Lineage, Inc. Reports Q3 2025 Financial Results

On November 5, 2025, Lineage, Inc. reported its financial results for the third quarter of 2025, showing a 3.1% increase in total revenue to $1,377 million, despite a GAAP net loss of $112 million. The company experienced growth in Adjusted EBITDA and AFFO, but faced challenges due to tariff uncertainty and lower occupancy in the US. Consequently, Lineage adjusted its full-year 2025 guidance to the lower end of previous ranges, while expressing optimism about long-term prospects due to declining new supply deliveries and growing demand for frozen food.

Lineage, Inc. Appoints New CFO and VP of Investor Relations

On October 17, 2025, Lineage, Inc. announced the appointment of Robb LeMasters as Chief Financial Officer, effective November 10, 2025, succeeding Robert Crisci who is retiring. LeMasters brings extensive experience from BWX Technologies and other financial firms, expected to drive growth and shareholder value. Additionally, Ki Bin Kim was appointed as Vice President of Investor Relations, bringing expertise from Truist Securities to strengthen investor relations and communicate the company’s strategic vision.